Montpellier, France

Guillaume Brandt

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 8.8

ph-index = 2

Forward Citations = 46(Granted Patents)


Location History:

  • Montpellier, FR (2013 - 2019)
  • Grabels, FR (2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Revolutionizing Viral Treatments: The Innovations of Guillaume Brandt

Introduction

Guillaume Brandt, an innovative inventor based in Montpellier, France, has made significant contributions to the field of virology through his groundbreaking patent work. With a total of five patents to his name, Brandt focuses on developing advanced nucleoside compounds that have the potential to treat various viral diseases.

Latest Patents

Brandt's latest patents include two notable inventions:

1. **Cyclic Phosphate Substituted Nucleoside Compounds and Methods of Use Thereof for the Treatment of Viral Diseases**

This invention features cyclic phosphate substituted nucleoside compounds that can be used for treating or preventing HCV infection in patients. The compounds, identified by specific formulas, are also related to pharmaceutically acceptable salts and various compositions containing these compounds.

2. **Amino Acid Phosphoramidate Pronucleotides of 2'-Cyano, Azido and Amino Nucleosides for the Treatment of HCV**

In this patent, Brandt describes compounds and methods designed to target Flaviviridae infections, such as HCV. The disclosed nucleoside derivatives can be utilized alone or in conjunction with other antiviral agents, showcasing their potential to enhance therapeutic effectiveness.

Career Highlights

Throughout his career, Guillaume Brandt has worked with esteemed companies in the pharmaceutical industry, including Idenix Pharmaceuticals, Inc. and Merck Sharp & Dohme Corporation. His experience at these organizations has equipped him with the expertise necessary to drive innovations in antiviral drug development.

Collaborations

In his journey as an inventor, Brandt has collaborated with notable colleagues such as Cyril B Dousson and David Dukhan. These partnerships underscore the importance of teamwork in advancing scientific research and developing new therapeutic strategies.

Conclusion

Guillaume Brandt is a distinguished inventor whose work is paving the way for new treatment options for viral infections. Through his innovative patents and collaborations, he continues to make a meaningful impact in the field of virology, offering hope for effective therapies against challenging diseases like HCV.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…